Alirocumab, CAS [[1245916-14-6]]

Product Overview

• Article Name: Alirocumab, CAS [[1245916-14-6]]
• Biozol Catalog Number: MCE-HY-P9928
• Supplier Catalog Number: HY-P9928
• Alternative Catalog Number: MCE-HY-P9928-100MG,MCE-HY-P9928-5MG,MCE-HY-P9928-25MG,MCE-HY-P9928-50MG,MCE-HY-P9928-10MG,MCE-HY-P9928-1MG
• Manufacturer: MedchemExpress
• Category: Antikörper
• Alternative Names: REGN 727, SAR 236553

Product Description

Alirocumab is an anti-PCSK9 human monoclonal antibody. Alirocumab inhibits PCSK9. Alirocumab reduces NLRP3 inflammasome, regulates Nrf2/HO-1, HMGB1/NF-kappaB and Fractalkine/CX3CR1. Alirocumab increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood. Alirocumab improves atherosclerosis and inflammation[1][2][3][4][5][6][7][8][9][10][11].

Product Properties

• Molecular Weight: (146.24 kDa)
• Purity: 97.00
• CAS Number: [1245916-14-6]
• Target: CX3CR1,HMG Family,Keap1-Nrf2,NF-kappaB,NOD-like Receptor (NLR),PCSK9

Application Notes

• Application Notes: MCE Product type: Inhibitory Antibodies